Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium folinate for protection against radiotherapy-related brain and auditory injury in lung cancer brain metastases
ChiCTR1900025490Phase 2Recruiting
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of folinic acid in bronchial carcinoma (2 arms), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Brain magnetic resonance imaging, Electrocardiogram and 3 more. Started Jan 2019; status: recruiting.
02
Drugs
folinic acid
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR1900025490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025490.